This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universitè De Genève. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thibaut De Smedt - Innovator in Cancer Treatment
Introduction
Thibaut De Smedt is an inventor based in Prévessin-Moëns, France. He is affiliated with the University of Geneva, where he contributes to research in the field of cancer treatment. His work focuses on developing new agents that can be used in immunotherapy for cancer patients.
Latest Patent Applications
Thibaut De Smedt has submitted a patent application titled "Adenosine 2A Receptor Modulators for Use in the Treatment of Cancer." This invention relates to new agents that are useful in treating cancers, particularly through immunotherapy. The application also includes pharmaceutically acceptable salts of these agents. Specifically, this invention provides new A2AR modulators, pharmaceutical compositions, and their uses.
Conclusion
Thibaut De Smedt is making significant strides in the field of cancer treatment through his innovative research and patent applications. His work has the potential to contribute greatly to the development of effective therapies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile